Princeton Capital Management LLC Pacira Bio Sciences, Inc. Transaction History

Princeton Capital Management LLC

$313 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $48,762 - $64,125	-1,350 Reduced 5.74%	22,153 $887,000
Q1 2023 May 01, 2023	SELL	$35.53 - $43.38 $27,464 - $33,532	-773 Reduced 3.18%	23,503 $959,000
Q4 2022 Jan 31, 2023	SELL	$38.19 - $57.45 $44,835 - $67,446	-1,174 Reduced 4.61%	24,276 $937,000
Q3 2022 Nov 10, 2022	BUY	$51.24 - $58.89 $46,679 - $53,648	911 Added 3.71%	25,450 $1.35 Million
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $18,896 - $29,961	-367 Reduced 1.47%	24,539 $1.43 Million
Q1 2022 May 11, 2022	SELL	$60.03 - $76.49 $20,110 - $25,624	-335 Reduced 1.33%	24,906 $1.9 Million
Q4 2021 Feb 09, 2022	BUY	$47.97 - $62.21 $43,988 - $57,046	917 Added 3.77%	25,241 $1.52 Million
Q3 2021 Nov 10, 2021	BUY	$54.64 - $61.3 $53,492 - $60,012	979 Added 4.19%	24,324 $1.36 Million
Q2 2021 Aug 11, 2021	BUY	$59.18 - $69.99 $49,356 - $58,371	834 Added 3.7%	23,345 $1.42 Million
Q1 2021 May 12, 2021	BUY	$59.31 - $78.82 $21,470 - $28,532	362 Added 1.63%	22,511 $1.58 Million
Q4 2020 Feb 11, 2021	BUY	$50.47 - $66.26 $25,235 - $33,130	500 Added 2.31%	22,149 $1.33 Million
Q3 2020 Nov 12, 2020	BUY	$51.97 - $63.0 $46,824 - $56,763	901 Added 4.34%	21,649 $1.3 Million
Q2 2020 Aug 10, 2020	BUY	$30.8 - $52.47 $149,749 - $255,109	4,862 Added 30.61%	20,748 $1.09 Million
Q1 2020 May 13, 2020	SELL	$28.4 - $50.7 $107,749 - $192,355	-3,794 Reduced 19.28%	15,886 $663,000
Q4 2019 Feb 12, 2020	SELL	$36.31 - $46.83 $44,261 - $57,085	-1,219 Reduced 5.83%	19,680 $931,000
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $1,034 - $1,304	-29 Reduced 0.14%	20,899 $796,000
Q2 2019 Aug 12, 2019	BUY	$36.57 - $47.97 $40,190 - $52,719	1,099 Added 5.54%	20,928 $910,000
Q1 2019 May 02, 2019	SELL	$36.47 - $42.17 $56,492 - $65,321	-1,549 Reduced 7.25%	19,829 $755,000
Q4 2018 Feb 13, 2019	SELL	$41.31 - $52.16 $263,970 - $333,302	-6,390 Reduced 23.01%	21,378 $920,000
Q3 2018 Nov 08, 2018	SELL	$32.85 - $52.0 $18,757 - $29,692	-571 Reduced 2.01%	27,768 $1.37 Million
Q2 2018 Aug 02, 2018	SELL	$27.5 - $39.8 $5,775 - $8,358	-210 Reduced 0.74%	28,339 $908,000
Q1 2018 May 03, 2018	SELL	$29.98 - $46.35 $14,660 - $22,665	-489 Reduced 1.68%	28,549 $889,000
Q4 2017 Feb 12, 2018	BUY	$31.85 - $46.95 $924,860 - $1.36 Million	29,038	29,038 $1.33 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Capital Management LLC with notifications on news.

Account